Cellular therapies for heart disease: Unveiling the ethical and public policy challenges

Journal of Molecular and Cellular Cardiology

Volumn 45, Issue 4, 2008, Pages 593-601

  Raval, Amish N ^a   Kamp, Timothy J ^a,b   Hogle, Linda F ^b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Bioethics; Cellular therapy; Clinical trials; Public policy; Regulation; Stem cells

Indexed keywords

CELL THERAPY; CELL TYPE; CLINICAL RESEARCH; CLINICAL TRIAL; EMBRYONIC STEM CELL; FOOD AND DRUG ADMINISTRATION; HEART DISEASE; HUMAN; MEDICAL ETHICS; NONHUMAN; PRIORITY JOURNAL; REVIEW; STEM CELL TRANSPLANTATION;

ADULT STEM CELLS; BIOETHICAL ISSUES; BIOETHICS; CARDIOVASCULAR DISEASES; ETHICS, MEDICAL; HUMANS; STEM CELL TRANSPLANTATION;

EID: 54149105039     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2007.11.005     Document Type: Review

References (32)

1. Asahara T., Murohara T., Sullivan A., Silver M., van der Z.R., Li T., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275 (1997) 964-967
2. Strauer B.E., Brehm M., Zeus T., Kostering M., Hernandez A., Sorg R.V., et al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 106 (2002) 1913-1918
3. Nadal-Ginard B., and Fuster V. Myocardial cell therapy at the crossroads. Nat Clin Pract Cardiovasc Med 4 (2007) 1
4. Steering Committee NHBLI CCTRN. Cardiac cell therapy: bench or bedside?. Nat Clin Pract Cardiovasc Med 4 (2007) 403
5. Srivastava D., and Ivey K.N. Potential of stem-cell-based therapies for heart disease. Nature 441 (2006) 1097-1099
6. Dimmeler S., Zeiher A.M., and Schneider M.D. Unchain my heart: the scientific foundations of cardiac repair. J Clin Invest 115 (2005) 572-583
7. Boyle A.J., Schulman S.P., Hare J.M., and Oettgen P. Is stem cell therapy ready for patients? Stem cell therapy for cardiac repair. ready for the next step. Circulation 114 (2006) 339-352
8. Menasche P., Hagege A.A., Vilquin J.T., Desnos M., Abergel E., Pouzet B., et al. Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J Am Coll Cardiol 41 (2003) 1078-1083
9. Werner N., Kosiol S., Schiegl T., Ahlers P., Walenta K., Link A., et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 353 (2005) 999-1007
10. Tepper O.M., Galiano R.D., Capla J.M., Kalka C., Gagne P.J., Jacobowitz G.R., et al. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 106 (2002) 2781-2786
11. Hurlbut W.B. Altered nuclear transfer: a way forward for embryonic stem cell research. Stem Cell Rev 1 (2005) 293-300
12. Meissner A., and Jaenisch R. Generation of nuclear transfer-derived pluripotent ES cells from cloned Cdx2-deficient blastocysts. Nature 439 (2006) 212-215
13. Melton D.A., Daley G.Q., and Jennings C.G. Altered nuclear transfer in stem-cell research - a flawed proposal. N Engl J Med 351 (2004) 2791-2792
14. Chung Y., Klimanskaya I., Becker S., Marh J., Lu S.J., Johnson J., et al. Embryonic and extraembryonic stem cell lines derived from single mouse blastomeres. Nature 439 (2006) 216-219
15. Solter D. Politically correct human embryonic stem cells?. N Engl J Med 353 (2005) 2321-2323
16. Takahashi K., and Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126 (2006) 663-676
17. Okita K., Ichisaka T., and Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature 448 (2007) 313-317
18. Guan K., Nayernia K., Maier L.S., Wagner S., Dressel R., Lee J.H., et al. Pluripotency of spermatogonial stem cells from adult mouse testis. Nature 440 (2006) 1199-1203
19. Holland S., Lebaczq K., and Zoloth L. The human embryonic stem cell debate: science, ethics and public policy (2001), MIT Press, Cambridge, MA
20. White House Domestic Policy Council. Advancing Stem Cell Sceince Without Destroying Human Life (1-6-2007)
21. Knowles L.P. A regulatory patchwork-human ES cell research oversight. Nat Biotechnol 22 (2004) 157-163
22. National Academies of Science. Guidelines for human embryonic stem cell research. Amendments 2007 (2005), National Academies Press, Washington DC
23. Hanson C., and Caisander G. Human embryonic stem cells and chromosome stability. APMIS 113 (2005) 751-755
24. Hill J.M., and Bartunek J. The end of granulocyte colony-stimulating factor in acute myocardial infarction? Reaping the benefits beyond cytokine mobilization. Circulation 113 (2006) 1926-1928
25. Olshansky B. Placebo and nocebo in cardiovascular health: implications for healthcare, research, and the doctor-patient relationship. J Am Coll Cardiol 49 (2007) 415-421
26. Menasche A., and Levine R.J. FDA revises informed consent regulations for emergency research. IRB 17 (1995) 19-22
27. Biros M.H., Lewis R.J., Olson C.M., Runge J.W., Cummins R.O., and Fost N. Informed consent in emergency research. Consensus statement from the Coalition Conference of Acute Resuscitation and Critical Care Researchers. JAMA 273 (1995) 1283-1287
28. Balsam L.B., Wagers A.J., Christensen J.L., Kofidis T., Weissman I.L., and Robbins R.C. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 428 (2004) 668-673
29. Mangi A.A., Noiseux N., Kong D., He H., Rezvani M., Ingwall J.S., et al. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med 9 (2003) 1195-1201
30. Daley G.Q., Ahrlund R.L., Auerbach J.M., Benvenisty N., Charo R.A., Chen G., et al. Ethics. The ISSCR guidelines for human embryonic stem cell research. Science 315 (2007) 603-604
31. International Stem Cell Initiative. Characterization of human embryonic stem cell lines by the International Stem Cell Initiative. Nat Biotechnol 25 7 (2007) 803-816
32. Jolicoeur E.M., Granger C.B., Fakunding J.L., Mockrin S.C., Grant S.M., Ellis S.G., et al. Bringing cardiovascular cell-based therapy to clinical application: perspectives based on a National Heart, Lung, and Blood Institute Cell Therapy Working Group meeting. Am Heart J 153 (2007) 732-742